These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 11738300)

  • 21. Absence of additional improvement in outcome of patients receiving cardiac resynchronization therapy paced at the most delayed left ventricular region.
    Deplagne A; Lafitte S; Reuter S; Reant P; Ploux S; Mokrani B; Roudaut R; Jais P; Haissaguerre M; Clementy J; DosSantos P; Bordachar P
    Arch Cardiovasc Dis; 2009; 102(8-9):641-9. PubMed ID: 19786268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time course of left ventricular volumes in severe congestive heart failure patients treated by optimized AV sequential left ventricular pacing alone--a 3-dimensional echocardiographic study.
    Butter C; Wellnhofer E; Seifert M; Schlegl M; Hoersch W; Goehring A; Fleck E
    Am Heart J; 2006 Jan; 151(1):115-23. PubMed ID: 16368302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
    D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration.
    Mischke K; Knackstedt C; Fache K; Reith S; Rana O; Saygili E; Gemein C; Becker M; Marx N; Schauerte P
    Acta Cardiol; 2011 Apr; 66(2):175-80. PubMed ID: 21591575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.
    Singh JP; Fan D; Heist EK; Alabiad CR; Taub C; Reddy V; Mansour M; Picard MH; Ruskin JN; Mela T
    Heart Rhythm; 2006 Nov; 3(11):1285-92. PubMed ID: 17074633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse left ventricular remodeling is more likely in non ischemic cardiomyopathy patients upgraded to biventricular stimulation after chronic right ventricular pacing.
    Morales MA; Startari U; Rossi G; Panchetti L; Rossi A; Piacenti M
    Cardiovasc Ultrasound; 2011 Dec; 9():41. PubMed ID: 22177469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy decreases the mitral coaptation point displacement in heart failure patients.
    Karagiannis SE; Maounis T; Athanassopoulos GD; Karatasakis GT; Hatzigeorgiou GH; Papadopoulos K; Leontiadis E; Cokkinos DV
    Hellenic J Cardiol; 2006; 47(4):198-205. PubMed ID: 16897922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short Term Outcome of Cardiac Resynchronization Therapy on Functional Recovery of Patients with Congestive Heart Failure in Bangladeshi Population.
    Ferdaushi UH; Ali MA; Islam N; Nabi S; Islam M; Alom MS; Paul GK
    Mymensingh Med J; 2019 Jan; 28(1):105-113. PubMed ID: 30755558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy.
    Pitzalis MV; Iacoviello M; Romito R; Guida P; De Tommasi E; Luzzi G; Anaclerio M; Forleo C; Rizzon P
    J Am Coll Cardiol; 2005 Jan; 45(1):65-9. PubMed ID: 15629375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac responses to left ventricular pacing in hearts with normal electrical conduction: beneficial effect of improved filling is counteracted by dyssynchrony.
    Boe E; Russell K; Remme EW; Gjesdal O; Smiseth OA; Skulstad H
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H370-8. PubMed ID: 24906920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time Course of Electrical Remodeling of Native Conduction After Cardiac Resynchronization Therapy and Its Impact on Clinical Outcome.
    Cvijić M; Žižek D; Antolič B; Zupan I
    J Card Fail; 2017 Mar; 23(3):257-261. PubMed ID: 27989870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.
    Zanon F; Marcantoni L; Baracca E; Pastore G; Lanza D; Fraccaro C; Picariello C; Conte L; Aggio S; Roncon L; Pacetta D; Badie N; Noventa F; Prinzen FW
    Heart Rhythm; 2016 Aug; 13(8):1644-51. PubMed ID: 27450156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiographic evaluation of cardiac dyssynchrony in patients with congestive heart failure.
    Qin C; Zhang L; Zhang ZM; Wang B; Ye Z; Wang Y; Nanda NC; Xie MX
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):434-441. PubMed ID: 27376817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy.
    Cimino S; Maestrini V; Cantisani D; Petronilli V; Filomena D; Gatto MC; Birtolo LI; Piro A; Lavalle C; Agati L
    Echocardiography; 2019 Aug; 36(8):1475-1481. PubMed ID: 31260156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
    Molhoek SG; Bax JJ; van Erven L; Bootsma M; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Apr; 93(7):860-3. PubMed ID: 15050489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term reverse remodeling by cardiac resynchronization therapy with MultiPoint Pacing: A feasibility study of noninvasive hemodynamics-guided device programming.
    Lercher P; Lunati M; Rordorf R; Landolina M; Badie N; Qu F; Casset C; Ryu K; Ghio S; Singh JP; Leclercq C
    Heart Rhythm; 2018 Dec; 15(12):1766-1774. PubMed ID: 29940305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of an additional left ventricular lead in cardiac resynchronization therapy nonresponders: The V
    Bordachar P; Gras D; Clementy N; Defaye P; Mondoly P; Boveda S; Anselme F; Klug D; Piot O; Sadoul N; Babuty D; Leclercq C
    Heart Rhythm; 2018 Jun; 15(6):870-876. PubMed ID: 29288035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remote past left ventricular function before chronic right ventricular pacing predicts responses to cardiac resynchronization therapy upgrade.
    Chang PC; Wo HT; Chen TH; Wu D; Lin FC; Wang CC
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):454-63. PubMed ID: 24251726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.